Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Keryx Biopharmaceuticals"
Count: 21
Selected: 0
| NCT ID | Title |
|---|
| NCT04523727 | Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease | ||
| NCT04649411 | Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease | ||
| NCT00130312 | Effect of Sulodexide in Overt Diabetic Nephropathy | ||
| NCT03236246 | KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) | ||
| NCT02128074 | A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia | ||
| NCT00130208 | Effect of Sulodexide in Early Diabetic Nephropathy | ||
| NCT02268994 | KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD | ||
| NCT01736397 | Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis | ||
| NCT00648167 | A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) | ||
| NCT00462202 | Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong | ||
| NCT01554982 | A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis | ||
| NCT01191255 | A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis | ||
| NCT00967993 | Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease | ||
| NCT01074125 | A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease | ||
| NCT03079869 | Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients | ||
| NCT03055598 | Ferric Citrate in ESRD Pilot Project | ||
| NCT02492620 | Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D | ||
| NCT00431054 | Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer | ||
| NCT02661295 | A Study of Ferric Citrate to Improve Inflammation and Lipid Levels | ||
| NCT00873457 | Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT00590954 | Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas |
